Fatal Pulmonary Mycobacterium Celatum Infection in an Immunocompetent Patient. An Eight-Year Follow-Up of the First Case, a Review of the Literature and a Report of Beta-2 Microglobulin as a Potential Indicator of Disease Severity

S. Rustscheff, J. Darelid

Department of Internal Medicine, V?rnamo General hospital and Department of Infectious diseases, Ryhov County hospital, J?nk?ping, Sweden..

DOI: 10.4236/aid.2013.34038                

Abstract

Setting: Swedish county hospital. Objective: Pulmonary M. celatum infection has been previously described only twice in an immunocompetent individual with no pre-existing chest disease. We describe the first Swedish case report of unusual drug-related complications and review the literature. Discussion: Atypical mycobacteriosis is often difficult to treat. We describe a fatal case of m celatum pneumonia in a previously healthy patient, unusual side effects encountered during her treatment and also the report of the utility of beta-2-microglobulin as a way to measure disease activity in mycobacterial infections. Conclusions: M. celatum may cause fatal pneumonia in previously healthy individuals. Treating the disease may be fraught with difficulty and there is a risk for very severe side effects, all of which must be weighed before taking the decision to treat this disease.

 

Keywords

Mycobacterium Celatum; Immunocompenent

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	W. R. Butler, S. P. O’Connor, M. A. Yakrus, R. W. Smithwick, B. B. Plikaytis, C. W. Moss et al., “Mycobacterium Celatum sp.nov,” International Journal of Systematic Bacteriology, Vol. 43, No. 3, 1993, pp. 539-548. http://dx.doi.org/10.1099/00207713-43-3-539
[2]	M. Valheim, B. Djönne, R. Heiene and D. A. Caugant, “Disseminated Mycobacterium Celatum (Type 3) Infection in a Domestic Ferret Mustela Putorius Furo),” Veterinary Pathology, Vol. 38, No. 4, 2001, pp. 460-463. http://dx.doi.org/10.1354/vp.38-4-460
[3]	M. F. Bertelsen, C. Gröndahl and S. B. Giese, “Disseminated Mycobacterium Celatum Infection in a White-Tailed Trogon (Trogon Viridis),” Avian Pathology, Vol. 35, No. 4, 2006, pp. 316-319. http://dx.doi.org/10.1080/03079450600821133
[4]	V. Beran, L. Matlova, L. Dvorska, P. Svastova and I. Pavlik, “Distribution of Mycobacteria in Clinically Healthy Ornamental Fish and Their Aquarian Environment,” Journal of Fish Diseases, Vol. 29, No. 7, 2006, pp. 383-393. http://dx.doi.org/10.1111/j.1365-2761.2006.00729.x
[5]	C. Piersimoni, E. Tortoli, F. de Lalla, D. Nista, D. Donato, S. Bornigia, et al., “Isolation of Mycobacterium Celatum from Patients Infected with Human Immunodeficiency Virus,” Clinical Infectious Diseases, Vol. 24, No. 2, 1997, pp. 144-147.
[6]	G. Haase, H. Skopnik, S. Bätge and E. C. Böttger, “Cervical Lymphadenitis Caused by Mycobacterium Celatum,” Lancet, Vol. 344, No. 8928, 1994, pp. 1020-1021. http://dx.doi.org/10.1016/S0140-6736(94)91680-2
[7]	D. C. Christiansen, G. D. Roberts and R. Patel, “Mycobacterium Celatum, an Emerging Pathogen and Cause of False Positive Amplified Mycobacterium Tuberculosis Direct Test,” Diagnostic Microbiology and Infectious Disease, Vol. 49, No. 1, 2004, pp. 19-24.
[8]	I. Bux-Gewehr, H. Hagen, S. Ruesch-Gerdes and G. Feurle, “Fatal Pulmonary Infection with Mycobacterium Celatum in an Immunocompetent Patient,” Journal of Clinical Microbiology, Vol. 36, No. 2, 1998, pp. 587-588.
[9]	J. H. T. Tjhie, A. F. van Belle, M. Dessens-Kroon and D. van Solingen, “Misidentification and Diagnostic Delay Caused by a False-Positive Amplified Mycobacterium Tuberculosis Direct Test in an Immunocompetent Patient with a Mycobacterium Celatum Infection,” Journal of Clinical Microbiology, Vol. 39, No. 6, 2001, pp. 2311-2312. http://dx.doi.org/10.1128/JCM.39.6.2311-2312.2001
[10]	C. Piersimoni, P. G. Zitti, D. Nista and S. Bornigia, “Mycobacterium Celatum Pulmonary Infection in the Immunocompetent: Case Report and Review,” Emerging Infectious Diseases Journal, Vol. 9, No. 3, 2003, pp. 339-342.
[11]	D. Christiansen, G. Roberts and R. Patel, “Mycobacterium Celatum, an Emerging Pathogen and Cause of False Positive Amplified Mycobacterium Tuberculosis Direct Test,”
[12]	J. Collazos, E. Martinez and J. Mayo, “Evolution of Serum Beta-2 Microglobulin Concentrations during Treatment of Tuberculosis Patients,” Scandinavian Journal of Infectious Diseases, Vol. 31, No. 3, 1999, pp. 265-267. http://dx.doi.org/10.1080/00365549950163554